Pay in 4 interest-free payments of $6.71 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Empower's focus has always been quality: compounding medications prescribed by licensed healthcare providers based upon individual patient needs, under rigorous compliance standards
As with any GLP1/GIP medication, it is important for healthcare providers to monitor patients taking GLP1/GIP medication to ensure it is being used safely and effectively
Executive summary RGA has quantified the expected mortality and morbidity impacts of incretin-based drugs, including GLP-1s, approved as anti-obesity medications (AOMs) and diabetes treatments in the US, UK, Canada, and Hong Kong
Key Characteristics: Mechanism: Binds to ghrelin receptors to stimulate growth hormone release from the pituitary gland Selective Action: Triggers GH release without significantly increasing cortisol or prolactin , making it more targeted and safer for long-term use compared to older secretagogues Half-life: Approximately 2 hours , so it is cleared quickly from the body
